<Anchor>



I delivered the news yesterday (the 9th) that the interval between vaccinations has increased due to a disruption in the amount of vaccines Moderna had planned to supply to Korea. Then, we will connect with a Washington correspondent to hear more about why Moderna failed to keep its promise with us.



Correspondent Kim Soo-hyung has been covering this content all the time. Has Moderna made an official position so far?



<Reporter>



I have tried to contact Moderna directly through various channels to get an explanation, but I haven't been able to get a proper explanation yet.



However, Moderna emailed SBS on the 27th of last month that it is experiencing supply delays outside the US due to laboratory problems, and that it will take two to four weeks to resolve it.



The 1.3 million doses of the Moderna vaccine that arrived in Korea on the 7th were the first to come from the United States.



It's not that the vaccine was produced in a place where there is a supply disruption.



<Anchor> It



is said that there is no problem with vaccines made in the US. So, can we not continue to receive vaccines made in the US?



<Reporter> The



US is expected to announce a booster shot of the corona vaccine, that is, a booster vaccination plan soon, due to the explosion of infections caused by the delta mutation.



It is a story that the vaccine, which has been circulating in the United States for a while, will soon be needed more.



There is an analysis that it may not be easy to export US-made vaccines as Americans have even invoked the Defense Production Act, which restricts the export of vaccine raw materials.



If the remainder of Moderna's supply to Korea was to be imported from outside the United States, it could be a sign that the delay in production is more serious than expected.



Earlier, CEO Bangsel Moderna made it clear in an interview with SBS in May that he would keep the supply contract with Korea.




[Stephane Bangsel/CEO Moderna (last May, SBS interview): The contract with Korea is to supply 40 million doses of vaccine.

We are actively working to meet the 40 million vaccine orders, and it will be in (Korea) over several months.] As



such, our government also needs to forcefully demand the execution of the contract from Moderna.



(Video coverage: Park Eun-ha, Video editing: Kim Ho-jin)